-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Id6bnQM3nI9VdIylV8eV99fFQ5EuKmHsIHzGR02gwSDowttg5anasHIiCBdYWrDi pBftB4Yv/7EXhNphqXQJ3g== 0001209191-07-006150.txt : 20070130 0001209191-07-006150.hdr.sgml : 20070130 20070130195026 ACCESSION NUMBER: 0001209191-07-006150 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070126 FILED AS OF DATE: 20070130 DATE AS OF CHANGE: 20070130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Solexa, Inc. CENTRAL INDEX KEY: 0000913275 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 943161073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: LYNX THERAPEUTICS INC DATE OF NAME CHANGE: 19931008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WHITFIELD ROY A CENTRAL INDEX KEY: 0000936728 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 07565993 BUSINESS ADDRESS: STREET 1: C/O INCYTE CORPORATION STREET 2: 3160 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 94304 MAIL ADDRESS: STREET 1: C/O INCYTE CORPORATION STREET 2: 3160 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 93404 4 1 bsf26824_bsf4rw.xml MAIN DOCUMENT DESCRIPTION X0202 4 2007-01-26 1 0000913275 Solexa, Inc. SLXA 0000936728 WHITFIELD ROY A C/O SOLEXA, INC. 25861 INDUSTRIAL BLVD. HAYWARD CA 94545 1 0 0 0 Stock Option (Right to Buy) 9.69 2007-01-26 4 D 0 20000 0.00 D 2016-10-13 Common Stock 20000 0 D Stock Option (Right to Buy) 9.69 2007-01-26 4 D 0 1014 0.00 D 2016-10-13 Common Stock 1836 0 D This option, which provided for vesting monthly and ratably over the 12 month period beginning on August 28, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 6,880 shares at an exercise price of $28.17 per share. This option, which provided for vesting monthly and ratably over the 12 month period beginning on October 4, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 348 shares at an exercise price of $28.17 per share. /s/ Roy A. Whitfield, by Kathy San Roman, attorney-in-fact 2007-01-29 -----END PRIVACY-ENHANCED MESSAGE-----